Literature DB >> 20974756

Pulmonary vein ostium shape and orientation as possible predictors of occlusion in patients with drug-refractory paroxysmal atrial fibrillation undergoing cryoballoon ablation.

Antonio Sorgente1, Gian Battista Chierchia, Carlo de Asmundis, Andrea Sarkozy, Mehdi Namdar, Lucio Capulzini, Yoshinao Yazaki, Stephan-Andreas Müller-Burri, Fatih Bayrak, Pedro Brugada.   

Abstract

AIMS: No specific data are available on the influence of pulmonary vein (PV) anatomy and shape on cryoballoon ablation (CA) catheter efficacy in delivering cryothermal energy and, consequently, in obtaining PV isolation. METHODS AND
RESULTS: Among a larger series of patients (68) with drug-refractory paroxysmal atrial fibrillation who underwent CA in our department, 52 patients were included in our study. All of them had a multislice cardiac computed tomography (MSCT) before the procedure. We retrospectively evaluated their MSCT scans focusing our attention on PV ovality and orientation in the frontal plane. A fair inverse association was documented between the ovality index of the left PVs and the degree of occlusion (r=-0.486 and P<0.003 for the LSPV and r=-0.360 and P=0.033 for the LIPV), whereas no association was found between the ovality index of the right PVs and the degree of occlusion (r=-0.283 and P=0.083 for the RSPV and r=0.235 and P=0.093 for RIPV). Nevertheless, a strong inverse association was found between the orientation of the PV ostia and the degree of occlusion in each vein (r=-0.804 and P<0.001 for the LSPV, r=-0.415 and P=0.013 for LIPV, r=-0.798 and P<0.001 for the RSPV, and r=-0.867 and P<0.001 for RIPV).
CONCLUSION: Pulmonary vein ostium shape and orientation evaluated by MSCT proved to be useful in predicting the degree of occlusion obtained during CA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20974756     DOI: 10.1093/europace/euq388

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  18 in total

1.  Temperature-guided ablation with the second-generation cryoballoon for paroxysmal atrial fibrillation: 3-year follow-up in a multicenter experience.

Authors:  Gaetano Paparella; Saverio Iacopino; Thiago Guimarães Osório; Juan Pablo Abugattas de Torres; Erwin Ströker; Juan Sieira; Hannes Vanacker; Bernard De Ruyter; Serge Boveda; Riccardo Maj; Gianluca Borio; Alessandro Rizzo; Alessio Galli; Pedro Brugada; Carlo de Asmundis; Gian-Battista Chierchia
Journal:  J Interv Card Electrophysiol       Date:  2020-05-31       Impact factor: 1.900

2.  FIRE or ICE for paroxysmal atrial fibrillation?-perspectives from the largest randomized evaluation of cryoballoon and radiofrequency ablation to date.

Authors:  Konstantinos C Siontis; Peter A Noseworthy
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

3.  Anatomical predictors for successful pulmonary vein isolation using balloon-based technologies in atrial fibrillation.

Authors:  Alexey Tsyganov; Jan Petru; Jan Skoda; Lucie Sediva; Pavel Hala; Jiri Weichet; Marek Janotka; Milan Chovanec; Petr Neuzil; Vivek Y Reddy
Journal:  J Interv Card Electrophysiol       Date:  2015-10-16       Impact factor: 1.900

4.  Conjoined Inferior Pulmonary Veins during Pulmonary Vein Isolation: Prevalence and Novel Approach for Pulmonary Vein Isolation with Cryoballoon.

Authors:  Jonathan Spagnola; Estelle Torbey; Rob Sangrigoli; John Harding; Marcin Kowalski
Journal:  J Atr Fibrillation       Date:  2015-04-30

5.  Medium-term results of cryoballoon ablation of the pulmonary veins in patients with paroxysmal and persistent atrial fibrillation. First experience of a Spanish center.

Authors:  Angel Ferrero-de Loma-Osorio; Maite Izquierdo-de Francisco; Angel Martínez-Brotons; Juan M Sánchez-Gómez; Beatriz Mascarell-Gregori; Vicente Ruiz-Ros; Isabel Cuenca-Romero; Roberto García-Civera; Francisco J Chorro-Gascó; Ricardo Ruiz-Granell
Journal:  J Interv Card Electrophysiol       Date:  2013-04-27       Impact factor: 1.900

6.  Regular atrial tachycardias following pulmonary vein isolation for paroxysmal atrial fibrillation: a retrospective comparison between the cryoballoon and conventional focal tip radiofrequency techniques.

Authors:  Justo Juliá; Gian-Battista Chierchia; Carlo de Asmundis; Giacomo Mugnai; Juan Sieira; Giuseppe Ciconte; Giacomo Di Giovanni; Giulio Conte; Giannis Baltogiannis; Yukio Saitoh; Kristel Wauters; Ghazala Irfan; Pedro Brugada
Journal:  J Interv Card Electrophysiol       Date:  2015-01-20       Impact factor: 1.900

7.  Effect of left atrial volume and pulmonary vein anatomy on outcome of nMARQ™ catheter ablation of paroxysmal atrial fibrillation.

Authors:  Giuseppe Stabile; Matteo Anselmino; Ezio Soldati; Ermengildo De Ruvo; Francesco Solimene; Assunta Iuliano; Luigi Sciarra; Maria Grazia Bongiorni; Leonardo Calò; Fiorenzo Gaita
Journal:  J Interv Card Electrophysiol       Date:  2016-10-06       Impact factor: 1.900

Review 8.  Outcomes Of Cryoballoon Ablation Of Atrial Fibrillation: A Comprehensive Review.

Authors:  Arash Aryana; Mark R Bowers; Padraig Gearoid O'Neill
Journal:  J Atr Fibrillation       Date:  2015-08-31

9.  Real-Time Recordings in Cryoballoon Pulmonary Veins Isolation: Comparison Between the 25mm and the 20mm Achieve Catheters.

Authors:  Francesca Salghetti; Juan-Pablo Abugattas; Valentina De Regibus; Saverio Iacopino; Ken Takarada; Erwin Ströker; Hugo-Enrique Coutiño; Ian Lusoc; Juan Sieira; Lucio Capulzini; Giacomo Mugnai; Vincent Umbrain; Stefan Beckers; Pedro Brugada; Carlo de Asmundis; Gian-Battista Chierchia
Journal:  J Atr Fibrillation       Date:  2018-04-30

10.  "Clinical Impact of the Cryoballoon Temperature and Occlusion Status on the Success of Pulmonary Vein Isolation".

Authors:  Takuro Nishimura; Kaoru Okishige; Yasuteru Yamauchi; Hideshi Aoyagi; Naruhiko Ito; Yusuke Tsuchiya; Takatoshi Shigeta; Rena Nakamura; Mitsutoshi Asano; Mitsumi Yamashita; Tomofumi Nakamura; Hidetoshi Suzuki; Tsukasa Shimura; Manabu Kurabayashi; Takehiko Keida; Tetsuo Sasano; Kenzo Hirao
Journal:  J Atr Fibrillation       Date:  2018-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.